Veterans Affairs to be first major insurer to cover Alzheimer’s drug Leqembi

Wall Street Journal

13 March 2023 - Roughly 168,000 veterans receiving care have Alzheimer’s dementia.

Eisai's new Alzheimer’s disease drug Leqembi will be covered by the US Department of Veterans Affairs, the first major insurer to agree to pay for the drug since its approval by US regulators earlier this year.

Read Wall Street Journal article (subscription required)

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Reimbursement , Veterans